Orme IM - Search Results

1

Current progress in tuberculosis vaccine development.

Orme IM. Orme IM. Vaccine. 2005 Mar 18;23(17-18):2105-8. doi: 10.1016/j.vaccine.2005.01.062. Vaccine. 2005. PMID: 15755579 Review.

2

Preclinical testing of new vaccines for tuberculosis: a comprehensive review.

Orme IM. Orme IM. Vaccine. 2006 Jan 9;24(1):2-19. doi: 10.1016/j.vaccine.2005.07.078. Epub 2005 Aug 8. Vaccine. 2006. PMID: 16139397 Review.

3

Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.

Basaraba RJ, Izzo AA, Brandt L, Orme IM. Basaraba RJ, et al. Among authors: orme im. Vaccine. 2006 Jan 16;24(3):280-6. doi: 10.1016/j.vaccine.2005.07.103. Epub 2005 Aug 24. Vaccine. 2006. PMID: 16153758

4

Tuberculosis vaccines: current progress.

Orme IM. Orme IM. Drugs. 2005;65(17):2437-44. doi: 10.2165/00003495-200565170-00002. Drugs. 2005. PMID: 16296870

5

Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Obregón-Henao A, Shanley C, Bianco MV, Cataldi AA, Basaraba RJ, Orme IM, Bigi F. Obregón-Henao A, et al. Among authors: orme im. Vaccine. 2011 Jun 10;29(26):4302-7. doi: 10.1016/j.vaccine.2011.04.027. Epub 2011 Apr 22. Vaccine. 2011. PMID: 21515327 Free PMC article.

6

Tuberculosis vaccine types and timings.

Orme IM. Orme IM. Clin Vaccine Immunol. 2015 Mar;22(3):249-57. doi: 10.1128/CVI.00718-14. Epub 2014 Dec 24. Clin Vaccine Immunol. 2015. PMID: 25540272 Free PMC article. Review.

7

Tuberculosis vaccine development: recent progress.

Orme IM, McMurray DN, Belisle JT. Orme IM, et al. Trends Microbiol. 2001 Mar;9(3):115-8. doi: 10.1016/s0966-842x(00)01949-1. Trends Microbiol. 2001. PMID: 11239788 Review.

8

Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.

Shanley CA, Streicher EM, Warren RM, Victor TC, Orme IM. Shanley CA, et al. Among authors: orme im. Vaccine. 2013 Dec 5;31(50):5934-9. doi: 10.1016/j.vaccine.2013.10.044. Epub 2013 Oct 19. Vaccine. 2013. PMID: 24144471 Free PMC article.

9

Incorporation of CpG oligodeoxynucleotide fails to enhance the protective efficacy of a subunit vaccine against Mycobacterium tuberculosis.

Hsieh MJ, Junqueira-Kipnis AP, Hoeffer A, Turner OC, Orme IM. Hsieh MJ, et al. Among authors: orme im. Vaccine. 2004 Jan 26;22(5-6):655-9. doi: 10.1016/j.vaccine.2003.08.035. Vaccine. 2004. PMID: 14741157

10

Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Shang S, Shanley CA, Caraway ML, Orme EA, Henao-Tamayo M, Hascall-Dove L, Ackart D, Orme IM, Ordway DJ, Basaraba RJ. Shang S, et al. Among authors: orme im, orme ea. Vaccine. 2012 Feb 21;30(9):1572-82. doi: 10.1016/j.vaccine.2011.12.114. Epub 2012 Jan 11. Vaccine. 2012. PMID: 22244979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters